---
title: 'Whole-body magnetic resonance imaging as a treatment response biomarker in castration resistant prostate cancer with bone metastases: iPROMET clinical trial'
date: 2018-11-28 15:15:26 +1000
icon: 'publications/pub12.png'
featured: true
weight: 2
year: 2024
draft: false
paperurl: 'https://doi.org/10.1016/j.eururo.2024.02.016'
---

Alonso Garcia-Ruiz, Carlos Macarro, Francesca Zacchi, Rafael Morales-Barrera, Francesco Grussu, Irene Casanova-Salas, Francesco Sanguedolce, Macarena Gonzalez, Matias de Albert, Josep Garcia-Benet, David Marmolejo, Jacques Planas, Sarai Roche, Richard Mast, Christina Zatse, Josep M Piulats, Bernardo Herrera-Imbroda, Lucas Regis, Laura Agundez, David Olmos, Nahum Calvo, Manuel Escobar, Joan Carles, Joaquin Mateo, Raquel Perez-Lopez. Whole-body magnetic resonance imaging as a treatment response biomarker in castration resistant prostate cancer with bone metastases: iPROMET clinical trial. *European Urology* (2024); doi: [10.1016/j.eururo.2024.02.016](https://doi.org/10.1016/j.eururo.2024.02.016).
